Cargando…

Evaluation of immune responses following infection of ponies with an EHV-1 ORF1/2 deletion mutant

Equine herpesvirus-1 (EHV-1) infection remains a significant problem despite the widespread use of vaccines. The inability to generate a protective immune response to EHV-1 vaccination or infection is thought to be due to immunomodulatory properties of the virus, and the ORF1 and ORF2 gene products...

Descripción completa

Detalles Bibliográficos
Autores principales: Soboll Hussey, Gisela, Hussey, Stephen B, Wagner, Bettina, Horohov, David W, Van de Walle, Gerlinde R, Osterrieder, Nikolaus, Goehring, Lutz S, Rao, Sangeeta, Lunn, David P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045331/
https://www.ncbi.nlm.nih.gov/pubmed/21314906
http://dx.doi.org/10.1186/1297-9716-42-23
_version_ 1782198813165879296
author Soboll Hussey, Gisela
Hussey, Stephen B
Wagner, Bettina
Horohov, David W
Van de Walle, Gerlinde R
Osterrieder, Nikolaus
Goehring, Lutz S
Rao, Sangeeta
Lunn, David P
author_facet Soboll Hussey, Gisela
Hussey, Stephen B
Wagner, Bettina
Horohov, David W
Van de Walle, Gerlinde R
Osterrieder, Nikolaus
Goehring, Lutz S
Rao, Sangeeta
Lunn, David P
author_sort Soboll Hussey, Gisela
collection PubMed
description Equine herpesvirus-1 (EHV-1) infection remains a significant problem despite the widespread use of vaccines. The inability to generate a protective immune response to EHV-1 vaccination or infection is thought to be due to immunomodulatory properties of the virus, and the ORF1 and ORF2 gene products have been hypothesized as potential candidates with immunoregulatory properties. A pony infection study was performed to define immune responses to EHV-1, and to determine if an EHV-1 ORF1/2 deletion mutant (ΔORF1/2) would have different disease and immunoregulatory effects compared to wild type EHV-1 (WT). Infection with either virus led to cytokine responses that coincided with the course of clinical disease, particularly the biphasic pyrexia, which correlates with respiratory disease and viremia, respectively. Similarly, both viruses caused suppression of proliferative T-cell responses on day 7 post infection (pi). The ΔORF1/ORF2 virus caused significantly shorter primary pyrexia and significantly reduced nasal shedding, and an attenuated decrease in PBMC IL-8 as well as increased Tbet responses compared to WT-infected ponies. In conclusion, our findings are (i) that infection of ponies with EHV-1 leads to modulation of immune responses, which are correlated with disease pathogenesis, and (ii) that the ORF1/2 genes are of importance for disease outcome and modulation of cytokine responses.
format Text
id pubmed-3045331
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30453312011-02-26 Evaluation of immune responses following infection of ponies with an EHV-1 ORF1/2 deletion mutant Soboll Hussey, Gisela Hussey, Stephen B Wagner, Bettina Horohov, David W Van de Walle, Gerlinde R Osterrieder, Nikolaus Goehring, Lutz S Rao, Sangeeta Lunn, David P Vet Res Research Equine herpesvirus-1 (EHV-1) infection remains a significant problem despite the widespread use of vaccines. The inability to generate a protective immune response to EHV-1 vaccination or infection is thought to be due to immunomodulatory properties of the virus, and the ORF1 and ORF2 gene products have been hypothesized as potential candidates with immunoregulatory properties. A pony infection study was performed to define immune responses to EHV-1, and to determine if an EHV-1 ORF1/2 deletion mutant (ΔORF1/2) would have different disease and immunoregulatory effects compared to wild type EHV-1 (WT). Infection with either virus led to cytokine responses that coincided with the course of clinical disease, particularly the biphasic pyrexia, which correlates with respiratory disease and viremia, respectively. Similarly, both viruses caused suppression of proliferative T-cell responses on day 7 post infection (pi). The ΔORF1/ORF2 virus caused significantly shorter primary pyrexia and significantly reduced nasal shedding, and an attenuated decrease in PBMC IL-8 as well as increased Tbet responses compared to WT-infected ponies. In conclusion, our findings are (i) that infection of ponies with EHV-1 leads to modulation of immune responses, which are correlated with disease pathogenesis, and (ii) that the ORF1/2 genes are of importance for disease outcome and modulation of cytokine responses. BioMed Central 2011 2011-02-07 /pmc/articles/PMC3045331/ /pubmed/21314906 http://dx.doi.org/10.1186/1297-9716-42-23 Text en Copyright ©2011 Hussey et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Soboll Hussey, Gisela
Hussey, Stephen B
Wagner, Bettina
Horohov, David W
Van de Walle, Gerlinde R
Osterrieder, Nikolaus
Goehring, Lutz S
Rao, Sangeeta
Lunn, David P
Evaluation of immune responses following infection of ponies with an EHV-1 ORF1/2 deletion mutant
title Evaluation of immune responses following infection of ponies with an EHV-1 ORF1/2 deletion mutant
title_full Evaluation of immune responses following infection of ponies with an EHV-1 ORF1/2 deletion mutant
title_fullStr Evaluation of immune responses following infection of ponies with an EHV-1 ORF1/2 deletion mutant
title_full_unstemmed Evaluation of immune responses following infection of ponies with an EHV-1 ORF1/2 deletion mutant
title_short Evaluation of immune responses following infection of ponies with an EHV-1 ORF1/2 deletion mutant
title_sort evaluation of immune responses following infection of ponies with an ehv-1 orf1/2 deletion mutant
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045331/
https://www.ncbi.nlm.nih.gov/pubmed/21314906
http://dx.doi.org/10.1186/1297-9716-42-23
work_keys_str_mv AT sobollhusseygisela evaluationofimmuneresponsesfollowinginfectionofponieswithanehv1orf12deletionmutant
AT husseystephenb evaluationofimmuneresponsesfollowinginfectionofponieswithanehv1orf12deletionmutant
AT wagnerbettina evaluationofimmuneresponsesfollowinginfectionofponieswithanehv1orf12deletionmutant
AT horohovdavidw evaluationofimmuneresponsesfollowinginfectionofponieswithanehv1orf12deletionmutant
AT vandewallegerlinder evaluationofimmuneresponsesfollowinginfectionofponieswithanehv1orf12deletionmutant
AT osterriedernikolaus evaluationofimmuneresponsesfollowinginfectionofponieswithanehv1orf12deletionmutant
AT goehringlutzs evaluationofimmuneresponsesfollowinginfectionofponieswithanehv1orf12deletionmutant
AT raosangeeta evaluationofimmuneresponsesfollowinginfectionofponieswithanehv1orf12deletionmutant
AT lunndavidp evaluationofimmuneresponsesfollowinginfectionofponieswithanehv1orf12deletionmutant